Cargando…
TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578476/ https://www.ncbi.nlm.nih.gov/pubmed/36226871 http://dx.doi.org/10.1080/13880209.2022.2096075 |
_version_ | 1784811971775823872 |
---|---|
author | Tian, Peng Wu, Lili Kudo, Maya Hayashi, Misa Qin, Lingling Gao, Ming Xu, Anlong Liu, Tonghua |
author_facet | Tian, Peng Wu, Lili Kudo, Maya Hayashi, Misa Qin, Lingling Gao, Ming Xu, Anlong Liu, Tonghua |
author_sort | Tian, Peng |
collection | PubMed |
description | CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats were divided into three groups: (1) 3.24 g/kg TNK (High TNK), (2) 1.62 g/kg TNK (Low TNK), and (3) an untreated control (CON). Wistar-Kyoto rats were used as normal controls (WKY). After 8 weeks of TNK oral administration, body weight, abdominal circumference, triglycerides (TC) and total cholesterol (CHO) were measured. Gut microbiota diversity was studied by 16S rDNA sequencing, and metagenomes analysis was conducted to determine alteration in functional gene expression. RESULTS: The body weight (496.60 ± 6.0 g vs. 523.40 ± 5.6 g), abdomen circumference (24.00 ± 0.11 cm vs. 24.87 ± 0.25 cm), TC (3.04 ± 0.16 mmol/L vs. 4.97 ± 0.21 mmol/L), CHO (2.42 ± 0.15 mmol/L vs. 2.84 ± 0.09 mmol/L) of rats in the High TNK group were decreased significantly (all p < 0.05). TNK administration regulates intestinal flora, up-regulates Eisenbergiella and down-regulates Clostridium_sensu_stricto_1, which is beneficial to the production of short-chain fatty acids (SCFAs). Metagenomes analysis shows that TNK is closely related to the fatty acid synthesis pathway. DISCUSSION AND CONCLUSIONS: TNK can regulate gut microbiota to reduce obesity, which may be related to fatty acid metabolism. Our research supports the clinical application of TNK preparation and provides a new perspective for the treatment of obesity. |
format | Online Article Text |
id | pubmed-9578476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-95784762022-10-19 TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions Tian, Peng Wu, Lili Kudo, Maya Hayashi, Misa Qin, Lingling Gao, Ming Xu, Anlong Liu, Tonghua Pharm Biol Research Article CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats were divided into three groups: (1) 3.24 g/kg TNK (High TNK), (2) 1.62 g/kg TNK (Low TNK), and (3) an untreated control (CON). Wistar-Kyoto rats were used as normal controls (WKY). After 8 weeks of TNK oral administration, body weight, abdominal circumference, triglycerides (TC) and total cholesterol (CHO) were measured. Gut microbiota diversity was studied by 16S rDNA sequencing, and metagenomes analysis was conducted to determine alteration in functional gene expression. RESULTS: The body weight (496.60 ± 6.0 g vs. 523.40 ± 5.6 g), abdomen circumference (24.00 ± 0.11 cm vs. 24.87 ± 0.25 cm), TC (3.04 ± 0.16 mmol/L vs. 4.97 ± 0.21 mmol/L), CHO (2.42 ± 0.15 mmol/L vs. 2.84 ± 0.09 mmol/L) of rats in the High TNK group were decreased significantly (all p < 0.05). TNK administration regulates intestinal flora, up-regulates Eisenbergiella and down-regulates Clostridium_sensu_stricto_1, which is beneficial to the production of short-chain fatty acids (SCFAs). Metagenomes analysis shows that TNK is closely related to the fatty acid synthesis pathway. DISCUSSION AND CONCLUSIONS: TNK can regulate gut microbiota to reduce obesity, which may be related to fatty acid metabolism. Our research supports the clinical application of TNK preparation and provides a new perspective for the treatment of obesity. Taylor & Francis 2022-10-13 /pmc/articles/PMC9578476/ /pubmed/36226871 http://dx.doi.org/10.1080/13880209.2022.2096075 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tian, Peng Wu, Lili Kudo, Maya Hayashi, Misa Qin, Lingling Gao, Ming Xu, Anlong Liu, Tonghua TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title | TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title_full | TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title_fullStr | TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title_full_unstemmed | TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title_short | TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions |
title_sort | tangnaikang, herbal formulation, alleviates obesity in diabetic shr/cp rats through modulation of gut microbiota and related metabolic functions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578476/ https://www.ncbi.nlm.nih.gov/pubmed/36226871 http://dx.doi.org/10.1080/13880209.2022.2096075 |
work_keys_str_mv | AT tianpeng tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT wulili tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT kudomaya tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT hayashimisa tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT qinlingling tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT gaoming tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT xuanlong tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions AT liutonghua tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions |